Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
A novel strategy to reduce the immunogenicity of biological therapiesJennifer Somerfield, Grant A Hill-Cawthorne, Andrew Lin, et al.
EJNMMI Research|July 16, 2020
Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRILaura M Lechermann, Roido Manavaki, Bala Attili, et al.
Brain : a Journal of Neurology|July 28, 2010
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunityJoanne L Jones, Jane M Anderson, Chia-Ling Phuah, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2019
Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumabJ William L Brown, Ferran Prados Carrasco, Arman Eshaghi, et al.
Brain : a Journal of Neurology|May 13, 2026
Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosisZoya G Georgieva, Sarah K Howlett, Daniel B Rainbow, et al.
Frontiers in Immunology|August 1, 2024
FlowAtlas: an interactive tool for high-dimensional immunophenotyping analysis bridging FlowJo with computational tools in JuliaValerie Coppard, Grisha Szep, Zoya Georgieva, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2014
Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopesMichael S Zandi, Ross W Paterson, Mark A Ellul, et al.
Brain, Behavior, and Immunity|February 2, 2020
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's diseaseRuwani S Wijeyekoon, Deborah Kronenberg-Versteeg, Kirsten M Scott, et al.
Journal of Neuroinflammation|January 23, 2024
Modeling the neuroimmune system in Alzheimer's and Parkinson's diseasesWendy Balestri, Ruchi Sharma, Victor A da Silva, et al.
Pageof 5